Bruce D Given's Net Worth
$32.5 Million
Who is Bruce D Given?
Bruce D Given has an estimated net worth of $32.5 Million. This is based on reported shares across multiple companies, which include ARROWHEAD RESEARCH CORP, and ENCYSIVE PHARMACEUTICALS INC.
SEC CIK
Bruce D Given's CIK is 0001219384
Past Insider Trading and Trends
2020 was Bruce D Given's most active year for acquiring shares with 11 total transactions. Bruce D Given's most active month to acquire stocks was the month of February. 2020 was Bruce D Given's most active year for disposing of shares, totalling 28 transactions. Bruce D Given's most active month to dispose stocks was the month of March. 2019 saw Bruce D Given paying a total of $439,600.00 for 416,000 shares, this is the most they've acquired in one year. In 2019 Bruce D Given cashed out on 885,750 shares for a total of $10,648,779.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARROWHEAD RESEARCH CORP (ARWR) Snapshot price: $22.22
Chief Operating OfficerBruce D Given owns 850,730 units of Common Stock which is worth $18,903,220.60. In the year 2011 Bruce D Given acquired a total of 1,666,653 shares in ARROWHEAD RESEARCH CORP at a cost of $609,055.66, Bruce also disposed a total of 815,923 shares of ARROWHEAD RESEARCH CORP equalling to $14,276,490.60.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.12% | -1.00K |
$24.23 | -$178,870.54 | 850.73K |
Scheduled
|
Apr 27 - Apr 28
| ||
Form 4
| -0.85% | -7.26K |
$24.07 | -$808,313.80 | 851.73K |
Scheduled
|
Apr 20
| ||
Form 4
| -3.98% | -35.61K |
$60.13 | -$2,141,285.21 | 858.99K |
Scheduled
|
Jan 6
| ||
Form 4
| +38.78% | 250K |
—
|
—
| 894.61K |
Jan 1
| |||
Form 4
|
—
|
0
|
$11.00 | -$764,150.00 | 644.61K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$10.50 | -$721,225.00 | 644.61K |
Scheduled
|
Feb 25
| ||
Form 4
| -3.91% | -26.25K |
$9.93 | -$1,142,562.50 | 644.61K |
Scheduled
|
Feb 15 - Feb 19
| ||
Form 4
| -20.88% | -177.00K |
$9.14 | -$3,747,686.92 | 670.86K |
Scheduled
|
Feb 8 - Feb 12
| ||
Form 4
| -2.59% | -22.50K |
$14.48 | -$325,800.00 | 847.86K |
Scheduled
|
Feb 5
| ||
Form 4
| -3.17% | -28.50K |
$13.85 | -$394,725.00 | 870.36K |
Scheduled
|
Feb 1
| ||
Form 4
| -15.87% | -169.50K |
$13.54 | -$2,295,805.00 | 898.86K |
Scheduled
|
Jan 22 - Jan 23
| ||
Form 4
| -2.73% | -30.00K |
$8.65 | -$577,625.48 | 1.07M |
Scheduled
|
Jan 14
| ||
Form 4
| +20.92% | 190K |
$11.98 | -$239,600.00 | 1.1M |
Scheduled
|
Jan 1 - Jan 2
| ||
Form 4
| -2.15% | -20.00K |
$6.73 | -$134,600.00 | 908.36K |
Scheduled
|
Mar 5
| ||
Form 4
| +20.04% | 155K |
$3.69 | -$73,800.00 | 928.36K |
Scheduled
|
Jan 1
| ||
Form 4
| +96.60% | 380K |
—
|
—
| 773.36K |
Jan 1
| |||
Form 4
| -3.36% | -13.68K |
$4.33 | -$59,212.75 | 393.36K |
Mar 4
| |||
Form 4
| -4.23% | -17.97K |
$3.46 | -$62,172.74 | 407.03K |
Feb 6
| |||
Form 4
| +54.55% | 150K |
—
|
—
| 425K |
Jan 1
| |||
Form 4
| +120.00% | 150K |
—
|
—
| 275K |
Mar 4 - Mar 6
| |||
Form 4
|
∞
| 125K |
—
|
—
| 125K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENCYSIVE PHARMACEUTICALS INC No price found
President & CEOBruce D Given owns 297,174 units of Common Stock.acquired a total of 90,991 shares in ENCYSIVE PHARMACEUTICALS INC at a cost of $38,987.60.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.77% | 31.3K |
—
|
—
| 297.17K |
Mar 14
| |||
Form 4
| +16.03% | 36.72K |
—
|
—
| 265.87K |
Mar 2
| |||
Form 4
| +0.88% | 2K |
$9.73 | $19,454.40 | 230.15K |
Oct 11
| |||
Form 4
| +3.71% | 8.17K |
—
|
—
| 228.15K |
Mar 1
| |||
Form 4
| +2.33% | 5K |
$5.85 | $29,268.50 | 219.98K |
Aug 4
| |||
Form 4
| +4.27% | 8.8K |
—
|
—
| 214.98K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||